Lv5
1530 积分 2024-08-13 加入
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond
14天前
已完结
A randomised, double‐blind, placebo‐controlled study of the LAG‐3‐depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis
1个月前
已完结
Preclinical evaluation and pilot clinical study of [18F]AlF-NOTA-FAPI-04 for PET imaging of rheumatoid arthritis
2个月前
已完结
Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer
2个月前
已完结
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer
2个月前
已完结
Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy
2个月前
已完结
A phase 2a trial of the IL-33 mAb tozorakimab in patients with COPD: FRONTIER-4
2个月前
已关闭
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2个月前
已完结
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
2个月前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
2个月前
已完结
皖公网安备34019202002308
